Call Matthew — SEC Form 4 filings

SEC reporting owner CIK 1816207. 3 Form 4 filings on record with FilingPulse; latest filed 2025-08-29.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-03-08 to 2025-08-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
iTeos Therapeutics, Inc. (ITOS)Chief Operating Officer310

Form 4 filings — Call Matthew

FiledFormIssuerReported transactionsSource
2025-08-294iTeos Therapeutics, Inc. (ITOS)Code (U): 161,898 · Disposition to issuer (D): 9,063 (derivative) · Disposition to issuer (D): 135,937 (derivative) · Disposition to issuer (D): 41,694 (derivative) · Disposition to issuer (D): 66,170 (derivative) · Disposition to issuer (D): 17,074 (derivative) · +1 moreEDGAR
2025-03-114iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 24,000 @ $0 · Grant/award (A): 145,000 (derivative) @ $0EDGAR
2024-03-084iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 225,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816207 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →